Huadong Medicine Co Ltd (000963) — Capital Reinvestment Ratio
Huadong Medicine Co Ltd (000963) has a Capital Reinvestment Ratio of 1.90x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥155.98 Million) in capital expenditures (CN¥297.09 Million). See Huadong Medicine Co Ltd balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Huadong Medicine Co Ltd Capital Reinvestment Ratio (1998–2024)
This chart tracks Huadong Medicine Co Ltd's Capital Reinvestment Ratio across 26 annual periods. Check cash flow reinvestment rate of Huadong Medicine Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Huadong Medicine Co Ltd (1998–2024)
Year-by-year Capital Reinvestment Ratio for Huadong Medicine Co Ltd from 1998 to 2024. For live market cap and broader valuation context, see Huadong Medicine Co Ltd market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.46x | CN¥3.75 Billion | CN¥1.73 Billion | ▲ +12.7% |
| 2023 | 0.41x | CN¥3.93 Billion | CN¥1.61 Billion | ▼ -18.4% |
| 2022 | 0.50x | CN¥2.38 Billion | CN¥1.19 Billion | ▲ +93.9% |
| 2021 | 0.26x | CN¥3.17 Billion | CN¥819.10 Million | ▼ -40.2% |
| 2020 | 0.43x | CN¥3.41 Billion | CN¥1.47 Billion | ▼ -36.1% |
| 2019 | 0.68x | CN¥2.00 Billion | CN¥1.35 Billion | ▲ +57.3% |
| 2018 | 0.43x | CN¥2.04 Billion | CN¥876.46 Million | ▲ +49.1% |
| 2017 | 0.29x | CN¥1.66 Billion | CN¥478.69 Million | ▼ -16.9% |
| 2016 | 0.35x | CN¥1.35 Billion | CN¥467.00 Million | ▼ -40.4% |
| 2015 | 0.58x | CN¥658.54 Million | CN¥383.01 Million | ▲ +32.6% |
| 2014 | 0.44x | CN¥740.85 Million | CN¥324.89 Million | ▼ -37.7% |
| 2013 | 0.70x | CN¥476.98 Million | CN¥335.84 Million | ▲ +76.1% |
| 2012 | 0.40x | CN¥642.73 Million | CN¥256.97 Million | ▼ -97.1% |
| 2011 | 13.91x | CN¥16.12 Million | CN¥224.21 Million | ▲ +6009.9% |
| 2009 | 0.23x | CN¥567.94 Million | CN¥129.26 Million | ▼ -11.1% |
| 2008 | 0.26x | CN¥344.69 Million | CN¥88.24 Million | ▲ +110.8% |
| 2007 | 0.12x | CN¥265.79 Million | CN¥32.27 Million | ▼ -91.7% |
| 2006 | 1.46x | CN¥57.38 Million | CN¥83.53 Million | ▲ +492.0% |
| 2005 | 0.25x | CN¥203.33 Million | CN¥50.00 Million | ▼ -95.4% |
| 2004 | 5.33x | CN¥12.51 Million | CN¥66.60 Million | ▲ +558.2% |
| 2003 | 0.81x | CN¥90.54 Million | CN¥73.24 Million | ▼ -65.7% |
| 2002 | 2.36x | CN¥23.94 Million | CN¥56.47 Million | ▲ +386.1% |
| 2001 | 0.49x | CN¥109.67 Million | CN¥53.21 Million | ▼ -85.6% |
| 2000 | 3.37x | CN¥19.59 Million | CN¥66.01 Million | ▲ +1565.3% |
| 1999 | 0.20x | CN¥56.32 Million | CN¥11.40 Million | ▼ -62.1% |
| 1998 | 0.53x | CN¥23.80 Million | CN¥12.70 Million | — |